STEQ America and PIERCAN new partnership
We are experiencing exponential development with respect to aseptic processes within the pharmaceutical and biotech sectors employing isolation technology at an accelerated frequency, a trend that has become progressively prevalent, if not the standard. According to current industry intelligence, the implementation of aseptic isolator technology has intensified by >250%, indicating the assurance and enhancement of sterility assurance and ultimately product safety and patient integrity. In reality, it is estimated that >70% of new pharmaceutical manufacturing facilities now encompass isolator technology, in one form or another, highlighting its critical role in meeting stringent regulatory requirements and guaranteeing the highest standards of product quality and patient safety.
In response to this upward demand for advanced aseptic processing solutions, STEQ America, in its pursuit of operational excellence for its product portfolio and clients, proudly combines PIERCAN with its distinguished portfolio. Headquartered in France, PIERCAN is recognized as a global leader in the manufacture of containment gloves for isolators, made in a variety of high-quality materials, for RABS, gloveboxes, and isolators. With more than 70 years in the market, PIERCAN’s irreproachable reputation is built on a continuous and high-performance quality system, supported by ISO 9001 certification, enabling it to meet the stringent requirements of its clients’ needs.
By integrating PIERCAN’s innovative products, STEQ America further reinforces its commitment to providing top-tier solutions that augment operational efficiency and safety in the pharmaceutical and biotech industries. Quality and innovation remain the cornerstones of both STEQ America and PIERCAN, driving their shared mission to strive for perfection, and along the way achieve product excellence.
To learn more or to get a quotation, please contact us at info@steqamerica.com